IP Library › Granted Patent US 8,114,976
Granted Patent B2
US 8,114,976 · App. 11/575,245 · Granted Feb 14, 2012

Patent

Assignee: Virginia Commonwealth University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,114,976
App. No.
11/575,245
Granted
Feb 14, 2012
Kind
B2
Abstract

Cryptosporidium hominis genes and gene products are provided. The genes and gene products are useful for chemotherapeutic, immunotherapeutic, immunoprophylactic and diagnostic applications.

Claims (2)

1. An isolated nucleic acid molecule encoding the polypeptide set forth as SEQ. ID. NO:8.

2. The isolated nucleic acid molecule of claim 1 , wherein said nucleic acid molecule is set forth as SEQ. ID. NO. 7.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 24, 2019
From: VIRGINIA COMMONWEALTH UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 049842/0889 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2009
From: BUCK, GREGORY; OZAKI, LUIS S.; WANG, YINGPING; XU, PING; SERRANO, MYMA GARCIA; MANQUE, PATRICIO A.; ALVES, JOAO M.P.; PUIU, DANIELA
To: VIRGINIA COMMONWEALTH UNIVERSITY
Reel/Frame 022975/0918 →
Continuity (2)
Provisional Application 60607356 · Sep 7, 2004
Related Publication 20090304732A1 · Dec 10, 2009